Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Vascular mEchanisms in, Stroke, dePression, dementiA, and deliRum: The VESPAR Project

Key facts

Where
Leicester, United KingdomSee the 2 sites

Where in United Kingdom

  • Leicestershire Partnership TrustLeicester, United KingdomNot yet recruiting
  • University Hospitals of Leicester NHS TrustLeicester, United KingdomTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Leicester
Trial code
NCT05649800
Record updated
1 December 2025
Original description
The goal of this observational study is to determine the feasibility of using integrated Transcranial Doppler Ultrasonography or Near Infrared Spectroscopy to detect changes in cerebral autoregulation and neurovascular coupling in healthy, stroke, dementia, depression and delirium populations. We also aim to:Read full original descriptionShow less

Evaluating the Feasibility of Remote Haemodynamic Monitoring in a Cohort of Multi-ethnic Chronic Stroke Patients Using a Novel User Interface and Artificial Intelligence Algorithms

The goal of this observational study is to determine the feasibility of using integrated Transcranial Doppler Ultrasonography or Near Infrared Spectroscopy to detect changes in cerebral autoregulation and neurovascular coupling in healthy, stroke, dementia, depression and delirium populations. We also aim to:

* Determine the optimal stimulus for neurovascular coupling * To derive sample size estimates for a future study * To develop a multilevel, multivariate model that can be applied to future datasets

Inclusion Criteria:; Healthy adults aged over 65 years, free from medical comorbidities or medications that can adversely affect cognitive function or cerebral haemodynamics; Stable, well controlled comorbidities (e.g. hypertension); A diagnosis of dementia (major neurocognitive disorder), depression, or delirium, according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V) criteria; Participants on or off anti-dementia drug therapy (acetylcholinesterase inhibitors, NMDA receptor antagonists), and antidepressants; A diagnosis of ischaemic (IS) or haemorrhagic (ICH) stroke according to clinical and/or radiological findings, within 72 hours of symptom onset; Exclusion Criteria:; Poorly controlled medical comorbidities affecting cerebral haemodynamics or cognitive function (e.g., heart failure, hypertension, type two diabetes); Clinically unstable or too unwell to cooperate with the study protocol; Lacks capacity or personal consultee to consent to the study.

ClinicalTrials.gov NCT05649800